Patents by Inventor Kathleen V. Callison

Kathleen V. Callison has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Treating disorders by application of insulin-like growth factors and analogs
    Patent number: 6723699
    Abstract: A method of enhancing the survival of neuronal cells in a mammal, the cells being at risk of dying, the method comprising administering to the mammal an effective amount of one of the following substances: IGF-I; a functional derivative of IGF-I; IGF-II; a functional derivative of IGF-II; IGF-III; or a functional derivative of IGF-III.
    Type: Grant
    Filed: April 22, 1998
    Date of Patent: April 20, 2004
    Assignee: Cephalon, Inc.
    Inventors: Michael E. Lewis, Kathleen V. Callison, Frank Baldino
  • Treating disorders by application of insulin-like growth factors and analogs
    Patent number: 6693076
    Abstract: A method of enhancing the survival of neuronal cells in a mammal, the cells being at risk of dying, the method comprising administering to the mammal an effective amount of one of the following substances: IGF-I; a functional derivative of IGF-I; IGF-II; a functional derivative of IGF-II; IGF-III; or a functional derivative of IGF-III.
    Type: Grant
    Filed: May 25, 1999
    Date of Patent: February 17, 2004
    Assignee: Cephalon, Inc.
    Inventors: Michael E. Lewis, James C. Kauer, Kevin R. Smith, Kathleen V. Callison, Frank Baldino
  • Treating disorders by application of insulin-like growth factors and analogs
    Patent number: 5776897
    Abstract: A method of enhancing the survival of neuronal cells in a mammal, the cells being at risk of dying, the method comprising administering to the mammal an effective amount of one of the following substances: IGF-I; a functional derivative of IGF-I; IGF-II; a functional derivative of IGF-II; IGF-III; or a functional derivative of IGF-III.
    Type: Grant
    Filed: March 24, 1997
    Date of Patent: July 7, 1998
    Assignee: Cephalon, Inc.
    Inventors: Michael E. Lewis, James C. Kauer, Kevin R. Smith, Kathleen V. Callison, Frank Baldino, Nicola Neff, Mohamed Iqbal
  • Treating disorders by application of insulin-like growth factors and analogs
    Patent number: 5703045
    Abstract: A method of enhancing the survival of neuronal cells in a mammal, the cells being at risk of dying, the method comprising administering to the mammal an effective amount of at least one of the following substances: IGF-I; a functional derivative of IGF-I; IGF-II; a functional derivative of IGF-II; IGF-III; or a functional derivative of IGF-III.
    Type: Grant
    Filed: June 5, 1995
    Date of Patent: December 30, 1997
    Assignee: Cephalon, Inc.
    Inventors: Michael E. Lewis, James C. Kauer, Kevin R. Smith, Kathleen V. Callison, Frank Baldino, Nicola Neff, Mohamed Iqbal
  • Treating disorders by application of insulin-like growth factors and analogs
    Patent number: 5652214
    Abstract: A method of enhancing the survival of neuronal cells in a mammal, the cells being at risk of dying, the method including the step of administering to the mammal one of the following substances: IGF-I; a functional derivative of IGF-I; IGF-II; a functional derivative of IGF-II; IGF-III; or a functional derivative of IGF-III.
    Type: Grant
    Filed: October 7, 1992
    Date of Patent: July 29, 1997
    Assignee: Cephalon, Inc.
    Inventors: Michael E. Lewis, James C. Kauer, Kevin R. Smith, Kathleen V. Callison, Frank Baldino, Nicola Neff, Mohamed Iqbal
  • Treating disorders by application of insulin-like growth factor
    Patent number: 5093317
    Abstract: Method of enhancing the survival of neuronal cells, more preferably non-mitotic neuronal cells and/or cholinergic cells in a mammal, which cells are at risk of dying, which method includes administering to the mammal an effective amount of a functional derivative of Insulin-like Growth Factor I or Insulin-like Growth Factor II.
    Type: Grant
    Filed: June 5, 1989
    Date of Patent: March 3, 1992
    Assignee: Cephalon, Inc.
    Inventors: Michael E. Lewis, James C. Kauer, Kevin R. Smith, Kathleen V. Callison, Frank Baldino, Jr.